Search Results - "Belhani, M"

Epidemiological and immunochemical parameters of monoclonal plasma cell dyscrasias of 2121 cases in Algeria by Belouni, R., Allam, I., Cherguelaine, K., Berkani, L., Belaid, B., Berkouk, Y., Nekkal, S., Saidani, M., Belhani, M., Ghaffor, M., Djidjik, R.

“…Plasma cell dyscrasias (PCD) are a heterogeneous group of diseases characterized by the expansion of monoclonal bone marrow plasma cells that produce a…”
Get full text

Establishing a harmonized haemophilia registry for countries with developing health care systems by Alzoebie, A., Belhani, M., Eshghi, P., Kupesiz, A. O., Ozelo, M., Pompa, M. T., Potgieter, J., Smith, M.

“…Summary Over recent decades tremendous progress has been made in diagnosing and treating haemophilia and, in resource‐rich countries, life expectancy of people…”
Get full text

IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay by Djidjik, R., Lounici, Y., Chergeulaïne, K., Berkouk, Y., Mouhoub, S., Chaib, S., Belhani, M., Ghaffor, M.

“…IgD multiple myeloma (MM) is a rare subtype of myeloma, it affects less than 2% of patients with MM. To evaluate the clinical and prognostic attributes of…”
Get full text

Epidemiological Study of Aplastic Anemia in Algeria for 844 Cases over 10 Years (2007-2016) by Mehdid, F, Rekkab, N, Oukid, S, Abad, MT, Bradai, M, Hamdi, S, Boukhemia, F, Hamladji, RM, Ahmed Nacer, R, Allouda, M, Ait Ali, H, Benaichou, S, Zouaoui, Z, Boughrira, S, Grifi, F, Cherif, N, Bensenouci, A, Kaci, Z, Belhani, M, Boudjerra, N, Serradj, F, Bekadja, MA, Kehal, M, Touhami, H, Saidi, D, Gareh, B, Saidi, M, Sahraoui, L, Ardjoun, Fz, Belakehal, SE, Chichoune, S, Ouarlhent, Y, Bendahmane, F, Mesli, N, Benhalilou, M, Sidi Mansour, N, Benmoufek, N, Ladj, S, Hadji, W, Bensmaine, N, Hendel, N, Arbaoui, F, Mehalhal, N, Hadji, S, Bachiri, A, Touati, L, Lakhdari, N, Ferroudj, N, Nekkal, S, Boudiaf, H, Achir, M, Fafa, A, Benakli, Malek

“…Introduction: The aim of this work is to establish an epidemiological approach of aplastic anemia (AA) in Algeria, to identify the different therapeutic…”
Get full text

Epidemiological Study on β-Thalassemia in Algeria by Grifi, Fatiha, Djenouni, A, Bougherira, S, Abad, MT, Boucherit, C, Boudjerra, N, Zidani, N, Aboura, C, Aribi, A, Belhani, M, Nekkal, S, Bouaricha, H, Benhassine, Fz, Ahmed Nacer, R, Tensaout, F, Ait amer, N, Hamladji, RM, Hamdi, S, Zatout, S, Sidi Mansour, N, Ouchenane, Z, Belakehal, SE, Mansour, H, Ghassoul, Y, Djilali, M, Ardjoun, Fz, Lakhdari, N, Touati, L, Bouterfa, N, Fenghour, R, Ait Ali, H, Graine, A, Allouda, M, Bouacha, A, Saidi, D, Sfaoui, W, Touhami, H, Bouchair, N, Hamani, N, Saidi, M, Nacib, R, Bekache, A, Dridi, R, Mesli, N, Houti, N, Ouarlhent, Y, Chichoune, S, Mehalhal, N, Zouaoui, Z, Benallal, A, Bekadja, MA, Benakli, Malek

“…Introduction : Among genetic diseases in hematology, β Thalassemia ranks second after sickle cell disorders in Algeria. Given the seriousness and cost of the…”
Get full text

Epidemiological Data from the Algerian Multiple Myeloma Registry (AMMR) over 2 Years (June 2014-June 2016): Report of the Algerian Multiple Myeloma Study Group (GETMA) by Saidi, M, Abad, MT, Taoussi, S, Ghezlane, C, Hamladji, RM, Ahmed Nacer, R, Belhadri, F, Moussaoui, H, Ait Ali, H, Aftisse, H, Ardjoun, Fz, Belakehal, SE, Rahali, C, Belhani, M, Boudjerra, N, Berkouk, Y, Ramaoun, M, Ahmidatou, H, Bekadja, MA, Talhi, S, Ouldjeriouat, H, Grifi, F, Boughrira, S, Smaili, K, Mesli, N, Bendahmane, F, Hamdi, S, Belkhodja, Fz, Amoura, A, Menia, H, Rechache, H, Zouaoui, Z, El mestari, A, Touhami, H, Mrabet, R, Lakhdari, N, Brahimi, Z, Zeghouati, S, Sidi Mansour, N, Benhalilou, M, Mehalhal, N, Bendjabellah, B, Chehili, W, Bachiri, A, Abderahmani, S, Ouarhlent, Y, Zidani, H, Nekkal, S, Bouchakor, Y, Hamouda, H, Mehdid, F, Saidi, D, Baichi, F, Benakli, M

“…Introduction: Multiple myeloma (MM) is the second hematological malignancy in Western countries with varying incidence across countries and ethnicities. In…”
Get full text

High-dose salvage chemotherapy without bone marrow transplantation for adult patients with refractory Hodgkin's disease by Tourani, J M, Levy, R, Colonna, P, Desablens, B, Leprise, P Y, Guilhot, F, Brahimi, S, Belhani, M, Ifrah, N, Sensebe, L

“…For patients with Hodgkin's disease (HD) who do not achieve complete response (CR), who experience a relapse within the first year of CR, and for those who…”
Get more information

Descriptive Study of Diffuse Large B Cell Lymphoma in Algeria and Tunisia over a Period of 5 Years by Boudjerra, N, Oukid, S, Abad, MT, Aboura, C, Louanchi, L, Ramaoun, M, Belhani, M, Allouda, M, Aftisse, H, Ait Ali, H, Ben lakhal, R, Meddeb, B, Ait Ameur, N, Belhadri, F, Tensaout, F, Ahmed Nacer, R, Hamladji, RM, Bougherira, S, Grifi, F, Ghassouli, Y, Djilali, M, Belakehal, SE, Ardjoun, Fz, Bouchama, S, Charef, L, Bekadja, MA, Benhalilou, M, Sidi Mansour, N, Kechichi, A, Hamdi, S, Bellaaj, H, Berber, B, Mesli, N, Zatla, L, Touhami, H, Laatiri, MA, Si Ali, N, Zouaoui, Z, Hamza, H, Ouarhlent, Y, Belkesmaoui, N, Ghedira, H, Khemiri, M, Mehalhal, N, Lakhdari, N, Saidi, M, Behloul, S, Lazzazi, A, Abrouk, S, Ben Othman, T, Benakli, M

“…Background: Diffuse Large B Cell Lymphoma (DLBCL) is the most common form of aggressive non-Hodgkin's lymphoma (NHL) accounting for approximately 40 % of all…”
Get full text

Epidemiology of Extranodal Diffuse Large B Cell Lymphomas in Algeria: A Study of the Algerian Group of Extranodal Lymphomas (GALEG) by Hamdi, S, Bentahar, I, Harbadji, H, Grifi, F, Bougherira, S, Filali, T, Smaili, F, Djabellah, A, Ait Ali, H, Allouda, M, Mesli, N, Berber, B, Bouzid, K, Sai, R, Hamladji, RM, Ahmed Nacer, R, Ait Ameur, N, Belhadri, F, Bekadja, MA, Charef, L, Touhami, H, Zatla, L, Belhani, M, Boudjerra, N, Nekkal, S, Louanchi, L, Saidi, M, Bougoufa, S, Bitam, M, Mehalhal, N, Abad, MT, Oukid, S, Ardjoun, Fz, Belakehal, SE, Sahraoui, L, Oukal, M, Zouaoui, Z, Si Ali, N, Bachiri, A, Belkesmaoui, L, Bendjabellah, B, Lamara, D, Lakhdari, N, Touati, L, Sidi Mansour, N, Ouarhlent, Y, Bouaoud, S, Kara, L, Benakli, M

“…Introduction: Primitive extranodal lymphomas are a heterogeneous group of malignant lymphoid hematological developed from the mucosa-associated lymphoid tissue…”
Get full text

Evaluation of the Imatinib Treatment of Patients with Chronic Myeloid Leukemia (CML). a Retrospective Study from Algerian Working Group on CML (GAT-LMC) by Djouadi, K, Bouchakour, A, Taoussi, S, Abad, MT, Ouchenane, Z, Sidi Mansour, N, Abdennebi, N, Harieche, F, Ahmed Nacer, R, Hamladji, RM, Touil, Fz, Hamdi, S, Entasoltane, B, Brahimi, M, Nachi, M, Bekadja, MA, Kerrar, C, Allam, L, Djidjik, O, Boudjerra, N, Belhani, M, Bougherira, S, Grifi, F, Gherras, S, Graine, A, Ait Ali, H, Brahimi, Z, Touati, L, Lakhdari, N, Mehalhal, N, Taibi, K, Touhami, H, Benzineb, B, Mesli, N, Saber Cherif, D, Rahali, C, Mansour, N, Meddour, Y, Chaib, S, Ardjoun, Fz, Maghraoui, F, Hadjeb, S, Zenori, M, Benlazhar, M, Zouaoui, Z, Baghdad, S, Bachiri, A, Lamara, D, Bendjabellah, B, Benakli, M

“…Introduction: The advent of anti-tyrosine kinase has revolutionized the treatment of chronic myeloid leukemia. Indeed, from 2000, the IMATINIB has become…”
Get full text

P-247 – Anomalies biologiques au cours du PTI: étude prospective by Kedji, L., Laraba, A., Belhani, M., Bensenouci, A., Khiari, M., Achir, M.

Get full text

Epidemiology and Clinical Features of Adults Myelodysplastic Syndromes in Algeria: A Population-Based Study. Review of the Algerian Myelodysplastic Syndromes Study Group by Bekadja, MA, Ahmed Nacer, R, Hamladji, RM, Boudjerra, N, Belhani, M, Ardjoun, Fz, Abad, MT, Touhami, H, Ait Ali, H, Zouaoui, Z, Sidi Mansour, N, Hamdi, S, Grifi, F, Mesli, N, Saidi, M, Lakhdari, N, Mehalhal, N, Bachiri, A, Bendjabellah, B, Nekkal, S, Osmani, S, Kaci, Z, Taoussi, S, Zouani, S, Graine, A, Benlazhar, M, Bouabellah, S, Benzineb, B, Belkhodja, Fz, Bougherira, S, Aiche, M, Aberkane, M, Touati, L, Benakli, M

“…BACKGROUND: In Algeria, the incidence of hematologic malignancies has been difficult to estimate for many years and MDS incidence is unclear because of…”
Get full text

Partial splenectomy in homozygous beta thalassaemia by de Montalembert, M, Girot, R, Revillon, Y, Jan, D, Adjrad, L, Ardjoun, F Z, Belhani, M, Najean, Y

“…Partial splenectomy was performed on 30 patients with homozygous beta thalassaemia to reduce blood requirements and to avoid the risk of overwhelming…”
Get full text

Epidemiological Approach of Chronic Myeloid Leukemia. Algerian-Tunisian Study by Djouadi, K, Abdennebi, N, Harieche, F, Ahmed Nacer, R, Hamladji, RM, Bouchakour, A, Taoussi, S, Abad, MT, Touil, Fz, Hamdi, S, Bougherira, S, Grifi, F, Kerrar, C, Allam, I, Djidjik, O, Boudjerra, N, Belhani, M, Gherras, S, Graine, A, Ait Ali, H, Entasoltane, B, Brahimi, M, Bekadja, MA, Ben lakhal, R, Meddeb, B, Ouchenane, Z, Sidi Mansour, N, Kacha, F, Tibermacine, F, Saidi, M, Mehalhal, N, Brahimi, Fz, Touati, L, Lakhdari, N, Saber Cherif, D, Meddour, Y, Chaib, S, Ardjoun, Fz, Bellaaj, H, Taibi, K, Touhami, H, Manai, HZ, Benzineb, B, Mesli, N, Maghraoui, A, Hadjeb, S, Zouaoui, Z, Baghdad, S, Bachiri, A, Laatiri, MA, Attari, M, Lamara, D, Bendjabellah, B, Ghedira, H, Ben Youcef, Y, Trabzi, A, Menif, S, Ben Othman, T, Benakli, M

“…Introduction: Chronic myeloid leukemia (CML) accounts for 7%-15% of all leukemias affecting adults. The incidence in Algeria is 0.4/100,000 inhabitants in…”
Get full text

Epidemiology and Clinical Features of Chronic Lymphoid Leukemia. Review of the Algerian Chronic Lymphoid Leukemia Study Group by Dali, N, Ait Ali, H, Tibiche, A, Belhadri, F, Harieche, F, Ahmed Nacer, R, Hamladji, RM, Taoussi, S, Oukid, S, Abad, MT, Kerrar, C, Boudjerra, N, Belhani, M, Bougherira, S, Grifi, F, Saidi, D, Touhami, H, Mahdad, S, Bekadja, MA, Bouhedda, Z, Hamdi, S, Ould Kablia, N, Ardjoun, Fz, Ouaddah, F, Zouaoui, Z, Bougofa, S, Saidi, M, Benhalilou, M, Sidi Mansour, N, Khiat, R, Mesli, N, Mehalhal, N, Brahimi, Z, Lakhdari, N, Bendjabellah, B, Bachiri, A, Benakli, M

“…Introduction: Chronic lymphocytic leukemia (CLL) is the most frequent leukemia of the adult in Europe and North Africa. It is rare on the Asian and African…”
Get full text

Indication de la transfusion sanguine chez les SDM by Ferroudj, N., Bensadok, M., Ramaoun, M., Belhani, M., Nekkal, S.

“…La drépanocytose est responsable de nombreux complications : les crises vaso-occlusives, l’hémolyse aiguë, le STA, l’AVC. La transfusion sanguine constitue…”
Get full text

Some aspects of 59Fe distribution in chicks and its incorporation into hemoglobin by Godet, J, Belhani, M

Get more information

Indirect evaluation of a gene frequency: calculation of beta-thalassemia frequency in Algeria based on associated hemoglobin variants frequency by Bachir, D, Belhani, M, Godet, J, Nigon, V, Colonna, P

“…The gene frequency (q) of beta-thalassemia (T) is more difficult to evaluate directly than the frequency of hemoglobin variants (V), Hb S and Hb C being the…”
Get more information

Hemoglobin H disease from Algeria: genetic and molecular characterization by Tabone, P, Henni, T, Belhani, M, Colonna, P, Verdier, G, Godet, J

“…A case of Hb H disease from Algeria was studied at the genetic and molecular level in order to delineate the pattern of alpha-thalassemia in the Mediterranean…”
Get more information

A population-based study of the epidemiology and clinical features of adults with acute myeloid leukemia in Algeria: report on behalf of the Algerian Acute Leukemia Study Group by Bekadja, Mohamed Amine, Hamladji, Rose Marie, Belhani, Meriem, Ardjoun, Fatima Zohra, Abad, Mohand Tayeb, Touhami, Hadj, Ait-Ali, Hocine, Zouaoui, Zahia, Sidimansour, Noureddine, Hamdi, Selma, Grifi, Fatiha, Mesli, Naima, Saidi, Mahdia, Mehalhal, Nemra, Bachiri, Aissa, Bouhass, Rachid, Said, Yousuf Mohamed, Midoun, Nouri

“…BACKGROUND AND OBJECTIVES In Algeria, the incidence of hematologic malignancies has been difficult to estimate for many years. Today, many hematological…”
Get full text